Dan Levy, PhD

Dan Levy, PhD, whose research also involves DNA methylation, is the recipient of an ICRF Project Grant at Ben-Gurion University of the Negev. Protein kinases (a type of enzyme) are important therapeutic targets in cancer because they may cause other molecules in the cell to become either active or inactive. Dr. Levy is focusing on the enzyme Aurora-B which plays an essential role in cell-cycle progression. Based on preliminary data obtained in his lab, he plans to test whether Aurora-B methylation plays a key role in the pathology of certain cancers and whether inhibiting the function of Aurora kinases could become a therapeutic target.

View Grant Recipient profile